Skip to main content
. Author manuscript; available in PMC: 2009 May 18.
Published in final edited form as: Clin Pharmacol Ther. 2007 Jul 25;83(2):312–321. doi: 10.1038/sj.clpt.6100290

Figure 1.

Figure 1

Time to major hemorrhage by CYP2C9 and VKORC1 genotype. Kaplan—Meier curves for time to major hemorrhagic complication analyses plotted for (a) CYP2C9 wild-type vs variant genotype and (b) VKORC1 1173C/T wild-type vs variant genotype. (c) Estimated survival curve from Cox PH model adjusted for VKORC1 1173C/T genotype, age, warfarin dose, gender, body mass index, INR, alcohol intake, vitamin K intake, number of comorbid conditions, and drug interactions (note: y axis starts at 0.98).